Effect of Diadenosine Tetraphosphate(AP<SUB>4</SUB>A) on Coronary Arterial Microvessels in the Beating Canine Heart
スポンサーリンク
概要
- 論文の詳細を見る
Diadenosine tetraphosphate (AP<SUB>4</SUB>A) can be released from activated platelets and the present study examined its effect on coronary arterial microvessels. The role of purinoceptors in the coronary microcirculation in vivo was also investigated. In open chest dogs, coronary arterioles were observed using a microscope with a floating objective. In Protocol 1, AP<SUB>4</SUB>A (1, 10, 100 and 1, 000μmol/L) was superfused onto the heart surface before and during the superfusion of 10μmol/L of 8-phenyltheophylline (8-PT), a P<SUB>1</SUB> purinoceptor blocker. In Protocol 2, AP<SUB>4</SUB>A (0.1, 1, 10, and 100 nmol·kg<SUP>-1</SUP>·min<SUP>-1</SUP>) was infused into the left anterior descending coronary artery before and during the superfusion of 10μmol/L of 8-PT. In addition to 8-PT, 30μmol/L of pyridoxalphosphate-6-azophenyl 2′, 4′-disulphonic acid (PPADS), a P<SUB>2X</SUB> purinoceptor blocker in Protocol 3, or 300μmol/L of N<SUP>ω</SUP>-nitro-L-arginine (LNNA) in Protocol 4, was continuously superfused, and 4 doses of AP<SUB>4</SUB>A were cumulatively superfused as in Protocol 1. In Protocol 5, 10μmol/L of α, β-methylene ATP, an agonist of P<SUB>2X</SUB> purinoceptors, was superfused for 60 min. Superfused AP<SUB>4</SUB>A dilated arterioles in a dose-dependent manner. The magnitude of dilatation was greater in smaller arterioles (small vessel ≤150μm: 24.5±2.2% vs large vessel > 150μm: 10.6±1.5% at a dose of 1, 000 μmol/L, p<0.001). On the other hand, intraluminally applied AP<SUB>4</SUB>A also dilated arterioles, but no size dependency was shown. In the presence of 8-PT, vasodilatory responses to superfused and intraluminally applied AP<SUB>4</SUB>A were attenuated and the lower doses of AP<SUB>4</SUB>A constricted arterioles. This vasoconstrictor effect was not affected by PPADS. The vasodilatory effect of the higher doses of AP<SUB>4</SUB>A was almost abolished in the presence of LNNA. α, β-methylene ATP had no effect on coronary microvascular diameters. AP<SUB>4</SUB>A has bidirectional effects on coronary arterial microvessels: vasodilatory effects mediated by P<SUB>1</SUB> purinoceptors and NO, which might be mediated by P<SUB>2Y</SUB> purinoceptors, and a vasoconstrictor effect, which is not mediated by P<SUB>2X</SUB> purinoceptors.
- 社団法人 日本循環器学会の論文
社団法人 日本循環器学会 | 論文
- Adenosine Triphosphate Exposes Dormant Pulmonary Vein Conduction Responsible for Recurrent Atrial Tachyarrhythmias : Importance of Evaluating the Dormant Conduction During the Re-Do Ablation Procedure
- Impact of Diabetes Mellitus on Rehospitalization for Heart Failure Among Survivors of Acute Myocardial Infarction in the Percutaneous Coronary Intervention Era
- N-Acetylcysteine Reduces the Severity of Atherosclerosis in Apolipoprotein E-Deficient Mice by Reducing Superoxide Production
- Incremental Effects of Eicosapentaenoic Acid on Cardiovascular Events in Statin-Treated Patients With Coronary Artery Disease : Secondary Prevention Analysis From JELIS
- Risk of Smoking and Metabolic Syndrome for Incidence of Cardiovascular Disease : Comparison of Relative Contribution in Urban Japanese Population : The Suita Study